Estradiol/drospirenone: BP-lowering effect in postmenopausal women

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1359, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estradiol/drospirenone improves postmenopausal symptoms

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension

By Mallareddy Madhavi

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 453-466

Adis International

Access to resources Recommend Favorite

Outcomes of Lipid-Lowering Treatment in Postmenopausal Women

By LaRosa J.C.

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 595-604

Adis International

Access to resources Recommend Favorite

The Effect of Washing and the Absence of Interindividual Transfer of Estradiol Gel: A Direct Skin-to-Skin Contact Study in Postmenopausal Women

By ZumBrunnen Troy L.

American Journal of Drug Delivery, Vol. 4, Iss. 2, 2006-01 ,pp. : 89-95

Adis International

Access to resources Recommend Favorite

Early addition of atorvastatin to effective BP-lowering treatment reduces the risk of heart attack

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite